CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Risk of Coronary Obstruction and Feasibility of Coronary Access After Repeat Transcatheter Aortic Valve Replacement With the Self-Expanding Evolut Valve: A Computed Tomography Simulation Study Mechanisms of in-stent restenosis after drug-eluting stent implantation: intravascular ultrasound analysis Ticagrelor versus clopidogrel in patients with acute coronary syndromes Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial Early Rhythm-Control Therapy in Patients with Atrial Fibrillation Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease Clinical Outcome After DK Crush Versus Culotte Stenting of Distal Left Main Bifurcation Lesions: The 3-Year Follow-Up Results of the DKCRUSH-III Study Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials Meta-Analysis of Comparison of 5-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Unprotected Left Main Coronary Artery in the Era of Drug-eluting Stents
|<<... 112 113 114 115 116 117 118 ...>>|

Original Research2020 Nov 6;127(11):e252-e270.

JOURNAL：Circ Res. Article Link

Sox17 Controls Emergence and Remodeling of Nestin-Expressing Coronary Vessels

S González-Hernández, MJ Gómez, F Sánchez-Cabo et al. Keywords: coronary vessel development; remodeling

Full Text PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top